UCSF

ZINC00538065

Substance Information

In ZINC since Heavy atoms Benign functionality
September 27th, 2005 33 Yes

Other Names:

1-(3-(4-(3-Chlorophenyl)piperazin-1-yl)propyl)-3-ethyl-4-(2-phenoxyethyl)-1H-1,2,4-triazol-5(4H)-one

1-(3-(4-(3-Chlorophenyl)piperazin-1-yl)propyl)-3-ethyl-4-(2-phenoxyethyl)-1H-1,2,4-triazol-5(4H)-one hydrochloride

1-(3-(4-(3-Chlorpheyl-1-piperazinylpropyl)-3-ethyl-4,5-dihydro-4-(2-phenoxyethyl)-1,2,4-triazol-5-on

1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta(sup 2)-1,2,4-triazolin-5-one monohydrochloride; 3H-1,2,4-Triazol-3-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl))propyl)-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, monohydrochlor

1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one

1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one; Nefazodone; nefazodone

2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one

2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3h-1,2,4-triazol-3-onehydrochloride

2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one

2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-5-ethyl-4-(2-phenoxyethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one

2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-5-ethyl-4-[2-(phenyloxy)ethyl]-2,4-dihydro-3H-1,2,4-triazol-3-one

3H-1,2,4-Triazol-3-one, 2,4-dihydro-2-3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-5-ethyl-4-(2-phenoxyethyl)-

3H-1,2,4-Triazol-3-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-

82752-99-6 (hydrochloride)

82752-99-6; D00819; Nefazodone hydrochloride (USAN); Serzone (TN)

83366-66-9

83366-66-9; C07256; Nefazodone

83366-66-9; D08257; Nefazodone (INN)

AC1L1I6V

BIDD:GT0789

BMY-13754

BMY-13754-1

BMY-13754; MJ-13754-1

BRD-K90789829-003-03-3

C07256

C25H32ClN5O2

CHEBI:7494

CHEMBL623

CID4449

CPD000449297; Nefazodone

CPD000449297; Nefazodone; SAM001247036

D08257

DAP000042

DB01149

Dutonin

HMS2090D17

INN); Nefazodone HCl (FDA

INN); Nefazodone Hydrochloride (FDA

L001196

LS-156497

Menfazona

MFCD00865396

MFCD00935760

MJ-13754-1

MLS000759458

MLS001165769

MLS001195657

MolPort-002-885-843

MolPort-003-849-346

NA

NCGC00165846-01

NCGC00165846-02

Nefadar

Nefazodona

Nefazodona [Spanish]

Nefazodona [Spanish];Nefazodonum [Latin]

nefazodona; nefazodone; nefazodonum

Nefazodone

Nefazodone (BAN

Nefazodone (hydrochloride)

Nefazodone (INN)

Nefazodone Hcl

Nefazodone [INN:BAN]

Nefazodonum

Nefazodonum [Latin]

QA-4240

Reseril

Rulivan

Serzone

SMR000550487

UNII-59H4FCV1TF

USAN)

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 4.06 14.82 -48.69 1 7 1 57 471.025 10
Mid Mid (pH 6-8) 4.06 12.61 -18.23 0 7 0 56 470.017 10

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 6.98e-02 g/l DrugBank-withdrawn
Purity 99% APIChem
Therapy antidepressant SMDC Iconix
Patent Database Links EP0769297; EP1000944; EP1078637; EP1627639; EP1700616; EP1731142; EP1782813; EP1844769; EP1867641; EP1879027; EP1941878; EP1990639; US2004142904; US2004254182; US2005009870; US2005014786; US2005026946; US2005080087; US2005085475; US2005187267; US200625871 ChEBI
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Tocris Cookson Ltd.; NCC_SUPPLIER_STRUCTURE_ID : 100675; 1 hydrogen chloride NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Tocris Bioscience; SUPPLIER_STRUCTURE_ID: 100675; SALT: 1 hydrogen chloride NIH Clinical Collection via PubChem

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
5HT2A-1-E Serotonin 2a (5-HT2a) Receptor (cluster #1 Of 3), Eukaryotic Eukaryotes 6 0.35 Binding ≤ 10μM
Q9WTR4-1-E Norepinephrine Transporter (cluster #1 Of 2), Eukaryotic Eukaryotes 570 0.26 Binding ≤ 10μM
SC6A2-1-E Norepinephrine Transporter (cluster #1 Of 2), Eukaryotic Eukaryotes 360 0.27 Binding ≤ 10μM
SC6A3-1-E Dopamine Transporter (cluster #1 Of 3), Eukaryotic Eukaryotes 360 0.27 Binding ≤ 10μM
SC6A4-1-E Serotonin Transporter (cluster #1 Of 4), Eukaryotic Eukaryotes 137 0.29 Binding ≤ 10μM
Z50466-1-O Trypanosoma Cruzi (cluster #1 Of 8), Other Other 8000 0.22 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
SC6A3_HUMAN Q01959 Dopamine Transporter, Human 360 0.27 Binding ≤ 1μM
SC6A2_HUMAN P23975 Norepinephrine Transporter, Human 360 0.27 Binding ≤ 1μM
Q9WTR4_RAT Q9WTR4 Norepinephrine Transporter, Rat 570 0.26 Binding ≤ 1μM
5HT2A_HUMAN P28223 Serotonin 2a (5-HT2a) Receptor, Human 5.8 0.35 Binding ≤ 1μM
SC6A4_RAT P31652 Serotonin Transporter, Rat 137 0.29 Binding ≤ 1μM
SC6A4_HUMAN P31645 Serotonin Transporter, Human 200 0.28 Binding ≤ 1μM
SC6A3_HUMAN Q01959 Dopamine Transporter, Human 360 0.27 Binding ≤ 10μM
SC6A3_RAT P23977 Dopamine Transporter, Rat 2380 0.24 Binding ≤ 10μM
Q9WTR4_RAT Q9WTR4 Norepinephrine Transporter, Rat 570 0.26 Binding ≤ 10μM
SC6A2_HUMAN P23975 Norepinephrine Transporter, Human 360 0.27 Binding ≤ 10μM
5HT2A_HUMAN P28223 Serotonin 2a (5-HT2a) Receptor, Human 5.8 0.35 Binding ≤ 10μM
SC6A4_RAT P31652 Serotonin Transporter, Rat 137 0.29 Binding ≤ 10μM
SC6A4_HUMAN P31645 Serotonin Transporter, Human 200 0.28 Binding ≤ 10μM
Z50466 Z50466 Trypanosoma Cruzi 8000 0.22 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Dopamine clearance from the synaptic cleft
G alpha (q) signalling events
Na+/Cl- dependent neurotransmitter transporters
Serotonin receptors

Analogs ( Draw Identity 99% 90% 80% 70% )